FDA go-ahead for TSC's OncoTrac medical imaging software

Over 3500 Total Lots Up For Auction at Seven Locations - France 06/21, PA 06/22, OK 06/23, UT 06/24, CA 06/25, NJ Cleansweep 06/29, MN 06/30

Signal de départ de FDA pour le logiciel médical de formation image d'OncoTrac du centre technique

par Diana Bradley, Staff Writer | November 23, 2011
Translational Sciences Corporation's
On Monday, Translational Sciences Corporation announced FDA 510(k) clearance for commercialization of its medical imaging software OncoTrac, designed to efficiently assess treatment response to breast, lung, colorectal, prostate, and lymphoma metastatic tumors.

"OncoTrac is a fantastic product," said Howard Pinsky, CEO of Cambridge, Mass.-based TSC. "It provides radiologists and oncologists with the opportunity to introduce definitive tumor assessments in patients going through chemotherapy treatment."

Featuring advanced report generation capabilities -- which can be exported and stored in both Picture and Archive Communications Systems and electronic medical records -- the software provides additional value through improved visualization of quantitative response to therapy.

Two Medical Facility Online Auctions! Call 314-429-4112

Midwest Hand Surgery Auction Closing 5/26 at 8PM. Hologic Fluoroscan Insight-FD Mini C-Arm, Nuvo Dual-Lamp Surgical Lighting System W/Control Panel, Ritter M11 Ultraclave Automatic Sterilizer & More! 2 Day Women's Treatment Center Auction Coming Soon!

OncoTrac's software utilizes tumor response assessments via criteria including RECIST 1.0, RECIST 1.1, WHO and Choi. Commonly required by clinical trial protocols, this criterion is often submitted as primary and secondary end-point data in new anti-cancer FDA drug approval applications.

Originally developed at the German Cancer Research Center by Mint Medical GmbH, OncoTrac's vendor-neutral platform is currently used under the brand Mint Lesion at major European cancer centers.

Next week's Annual Meeting of the Radiological Society of North America in Chicago will include an OncoTrac demonstration.

You Must Be Logged In To Post A Comment